XCSE
DEMANT
Market cap9.63bUSD
Sep 11, Last price
294.40DKK
1D
0.34%
1Q
17.20%
Jan 2017
139.74%
Name
Demant A/S
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Demant A/S is a leading global enterprise specializing in the fields of hearing healthcare and audio technology. The company's primary focus is on the research, production, and sale of advanced solutions and devices aimed at enhancing individuals' hearing abilities across Europe, North America, the Pacific region, Asia, and other international territories. Its operations are strategically divided into two core segments: Hearing Healthcare and Communications. The Hearing Healthcare division provides a comprehensive suite of offerings, including hearing implants, assistive listening devices, audiological care services, and diagnostic equipment. Conversely, the Communications segment is dedicated to furnishing high-quality headsets for collaborative professional environments and the competitive gaming market, distributed under its EPOS brand. Originally established in 1904, the organization was previously known as William Demant Holding A/S, officially adopting its current name, Demant A/S, in March 2019. The corporate headquarters for Demant A/S are located in Smørum, Denmark.
Related entities
Parent
WILLIAM DEMANT FONDEN
Subsidiaries
OTICON A/S
Key people
Rene Schneider
Chief Financial Officer, Member of the Executive Board · since 2015
Deputy Chairman of the Board · since 2017
Headquarters & legal address
KONGEBAKKEN 9
SMØRUM, 84 2765
DK
SMØRUM, 84 2765
DK
Previous name
WILLIAM DEMANT HOLDING A/S
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||